Resolution
- RDC 105 of May 31, 2001 (*)
Federal
Official Gazette - DOU of 13/12/2001
The
Collegiate Board of Directors of the National Sanitary Surveillance
Agency, in pursuance of the prerogatives conferred upon the Board
by Article11, Numeral IV, of the Regulation of ANVISA as approved
by Decree 3.029, of April 16, 1999, c/c paragraph 1 of Article111,
Clause I, item "b", of the Bylaws approved by Administrative
Rule 593 of August 25, 2000, republished in the Federal Official
Gazette - DOU - DOU of December 22, 2000, at their meeting convened
on May 30, 2001,
WHEREAS
the
provisions set forth in Law 9.782, of January 26, 1999, which determine
the regulation, monitoring and inspection of products and services
that involve a risk to public health,
has
adopted the following Resolution, applicable to tobacco leaves and
tobacco products which are processed, manufactured, transported, marketed
and/or stored throughout the territory of Brazil , and whether imported
or for purposes of export.
Article
1 - All Brazilian national manufacturing companies and companies which
import or export products derived from tobacco, whether smokable
or not, must be compulsorily registered, all the products derived
therefrom and tobacco processing companies must be registered annually.
Sole
Paragraph - For the purposes of this Resolution, the following definitions
apply:
I
- Processing company: any company headquartered in Brazilian territory
which purchases, processes and stores tobacco leaves for the purpose
of commercialization to national or foreign companies that manufacture
tobacco products;
II
- National manufacturing company: any company headquartered in Brazilian
territory which processes or manufactures any product derived from
tobacco, whether smokable or not, for the purpose of commercialization
in the Brazilian domestic and/or foreign market;
III
- Importing company: any company which imports processed tobacco or
any manufactured product derived from tobacco, whether smokable or
not, with the purpose of distribution or commercialization in the
Brazilian domestic market.
IV
- Exporting company: any company which exports processed tobacco or
any manufactured product derived from tobacco, whether smokable or
not, with the purpose of distribution or commercialization in the
foreign market.
Registration
of the Company
Article
2 - All tobacco processing companies,
national manufacturing companies, importers or exporters of products
derived from tobacco, whether smokable or not, must present an application
for registration to the Docket Sector of ANVISA. The application
must be supported by the following documents:
I
- Form 1 – Company Registration Information; and
II
- A Statement, registered at a Public Notary Office, indicating the
qualifying status of the company making the application, in accordance
with its size, and in line with the model shown in the annex of Resolution
RDC no 6 of 2 January 2001, which can be obtained on the homepage
of ANVISA, http://www.anvisa.gov.br.
Paragraph
1 - In the case of tobacco processing companies, the registration
application must also be accompanied by the data on the processed
tobacco throughout the fiscal year, included in Form 2 - General
List of Types of Tobacco and Additives Used, displayed in the Annex.
Paragraph
2 - After the company has been duly registered, any alteration of
this information must be directed to ANVISA within a maximum period
of 30 (thirty) days from the date the information is modified.
Paragraph
3 - The form required for registration of the company, displayed in
the Annex, is available on-line, from the System for the Registration
of Tobacco Products (SISTAB), which can be found on the electronic
page of ANVISA, and can also be obtained directly from ANVISA headquarters.
Paragraph
4 - The information completed on the SISTAB system must be handed
over in diskette or CD-ROM to the Docket Sector of ANVISA upon application
for registration.
Deadlines for Company Registration
Article
3 - The application for company registration is to be forwarded only
once.
Sole
paragraph - The application for registration of processing company
is to be forwarded annually by January 31 of the year following the
fiscal year.
Registration
of the Product
Article
4 - All national manufacturing companies, as well as those companies
which import or export tobacco products, whether smokable or not,
must present to the Docket Sector of ANVISA a separate application
for registration for each product marketed under a brand name, applicable
to each product according to the features distinguishing it from
others such as tar levels, composition, flavor, aroma and others.
Paragraph 1 - The application for registration must
be supported by the following documentation:
I
– An original receipt proving payment of the Inspection Fee effected
through the Sanitary Surveillance Fee Collection Voucher (GRVS),
drawn up under RDC 28 of December 20, 1999, and available on the
electronic page of ANVISA, or by completing the Federal Tax Collection
Voucher (DARF). Instructions on how to fill out the latter can also
be obtained from the ANVISA electronic page.
II
– A photocopy in color of the complete packaging intended for presentation
to the end consumer, in accordance with the instructions set forth
in Resolution RDC 104, of May 31, 2001;
III
– The registration details referring to the production, sale and composition
of the product according to the type of product.
Cigarettes
Article
5 - Regarding cigarettes, the registration data included in the following
forms and tables, published in Annex, shall be required:
I - Form 2 – General List of Types of Tobacco and Additives
Used;
II - Form 3 - Product Registration Information
III - Table 1 - Composition of the Product - type
and amount of tobacco used in the product;
IV - Table 2 - Composition of the Product - additives
contained in the product;
V
- Table 3 - Composition of the Product - specifications of the filter
and wrappers;
VI - Table 4 - Composition of the Product - studies
undertaken;
VII - Table 5 - Compounds present in the mainstream
smoke of the product;
VIII - Table 6 - Compounds present in the sidestream
smoke of the product;
IX - Table 7 - Compounds present overall in the tobacco;
X
- Table 8 - Data regarding Sale and Production - monthly amount
of the product sold per (Brazilian) state ;
XI
- Table 9 - Data regarding Sale and Production - monthly amount exported,
according to country of destination;
XII
- Table 10 - Data regarding Sale and Production - monthly amount
imported , according to country of origin;
XIII
- Table 11 - Data regarding Sale and Production - monthly amount
produced; and
XIV
- Table 12 - Data regarding Sale and Production - monthly sale price
charged to consumers according per (Brazilian) state).
Smokable tobacco products, except cigarettes
Article
6 - For smokable tobacco products, except cigarettes, the registration
data included in the following forms and tables, published in Annex,
shall be required:
I - Form 2 – General List of Types of Tobacco and Additives
Used;
II - Form 3 - Product Registration Information
III - Table 1 - Composition of the Product - type
and amount of tobacco used in the product;
IV - Table 2 - Composition of the Product - additives
contained in the product;
V - Table 4 - Composition of the Product - studies undertaken;
VI - Table 7 - Compounds present overall in the tobacco
- companies may present a summary report containing only pH determination
and nicotine, ammonia and euginol levels present in overall tobacco;
VII
- Table 8 - Data regarding Sale and Production - monthly amount
of the product sold per (Brazilian) state ;
VIII
- Table 9 - Data regarding Sale and Production - monthly amount exported,
according to country of destination;
IX
- Table 10 - Data regarding Sale and Production - monthly amount
imported , according to country of origin;
X
- Table 11 - Data regarding Sale and Production - monthly amount
produced; and
XI
- Table 12 - Data regarding Sale and Production - monthly sale price
charged to consumers according per (Brazilian) state).
Non-smokable tobacco products
Article 7 - For non-smokable tobacco products the registration
data contained in the following forms and tables, published in Annex,
shall be required:
I - Form 2 – General List of Types of Tobacco and Additives
Used;
II - Form 3 - Product Registration Information
III - Table 1 - Composition of the Product - type
and amount of tobacco used in the product;
IV - Table 2 - Composition of the Product - additives
contained in the product;
V - Table 4 - Composition of the Product - studies undertaken;
VI - Table 7 - Compounds present overall in the tobacco
- companies may present a summary report containing only pH determination
and nicotine, ammonia and euginol levels present in overall tobacco;
VII
- Table 8 - Data regarding Sale and Production - monthly amount
of the product sold per (Brazilian) state ;
VIII
- Table 9 - Data regarding Sale and Production - monthly amount exported,
according to country of destination;
IX
- Table 10 - Data regarding Sale and Production - monthly amount
imported , according to country of origin;
X
- Table 11 - Data regarding Sale and Production - monthly amount
produced; and
XI
- Table 12 - Data regarding Sale and Production - monthly sale price
charged to consumers according per (Brazilian) state).
Article
8 - The forms and the tables published in the Annex are available
electronically from the System for the Registration of Tobacco Products
(SISTAB), available on the electronic page of ANVISA. In addition,
or alternatively, the relevant forms can be obtained directly from
ANVISA headquarters.
Sole
Paragraph - The information filled out on the SISTAB system must be
delivered in diskette or CD-ROM form to the Docket Sector of ANVISA
upon application for registration. Printed copies of the filled out
forms will not be accepted.
Article
9 - Estimated data will not be accepted on levels of compounds present
in the mainstream and sidestream smoke of the product and of the overall
tobacco, obtained through benchmarking or any other data prognosis
technique.
Exemptions from Product Registration
Article
10 - Smokable tobacco products, including cigarettes, manufactured
within the Brazilian territory exclusively for the purpose of exportation,
shall be exempted from payment of the inspection fee and from providing
the information required in Tables 5, 6, 7, 8, 10 and 12.
Deadlines for Product Registration
Article
11. In order to comply with the provisions set out in this Resolution,
the application for registration of products must be forwarded on
an annual basis, in the year following the year of commercialization
of the product, by January 31.
Article
12 - In order to comply with the provisions set out in this Resolution,
the application for registration of new products to be commercialized
must be carried out in two stages:
I
- forwarding of initial information, until 3 (three) days before marketing
of the product commences, constituting a pre-registration of the product;
and
II
- the request for conclusion of registration must be accompanied by
the original proof of payment of the inspection fee, of photocopy
in color of the complete packaging intended for presentation to the
end consumer, of Form 2 and of Tables 5 to 12, as provided for in
articles 4, 5, 6,and 7.
General
Provisions
Article
13 - Once the procedures set forth in the aforementioned Articles
have been complied with, the registration applications sent to ANVISA
will be examined by the Office of Smoking Products of ANVISA, under
the technical supervision of the National Cancer Institute Coordination
Office for Prevention and Surveillance (Conprev/INCA/MS).
Article 14 - The registration application may be rejected
when:
I. the requirements detailed in this Resolution are
not complied with;
II.
the technical requirements referring to the said products are not
complied with.
Article
15 - In the event of the registration application being rejected,
the requesting company may appeal to the Supervising Director of the
Office of Smoking Products of ANVISA within a period of 30 (thirty)
days from the date of the rejection of the application. The decision
taken at the administrative level will be final.
Article
16 - The marketing in Brazilian national territory of any tobacco
product, smokable or not, is prohibited unless it is duly registered
in the Brazilian Sanitary Surveillance Agency.
Sole
paragraph - Every product marketed in the national territory, including
those destined to market research, whose registration application
has not been forwarded or has not been accepted shall be immediately
removed from the consumer market by the Brazilian manufacturer of
the same, or by the importer of the product.
Article
17 - Non-compliance with the provisions set forth under this Resolution
constitutes a sanitary violation and the offender will render himself
liable to the penalties provided for in Law 6.437 of August 20, 1977
and in Federal Law 9.294 of July 15, 1996.
Article
18 - The Brazilian Sanitary Surveillance Agency, through the Office
of Smoking Products, may set forth normative instructions for situations
not provided for in this Resolution.
Article
19 - Resolution 320 of July 21, 1999 and Resolution 2, issued by
the Collegiate Board of Directors on October 4, 1999, are both hereby
revoked.
Article 20 - This Resolution enters into force on the
date of its re-publication.
GONZALO VECINA NETO
(*)Republished
on account of errors in the original version, published in the Federal
Official Gazette - DOU - DOU, on December 13, 2001, page 242, section
J.
Additional information on the carcinogenic potential
of some of the components present in or generated by tobacco products
Tobacco-based
cigarette smoke contains 4720 toxic substances. Among them is tar,
which comprises carcinogenic substances, carbon monoxide, which impedes
the taking in and circulation of oxygen by the human organism, and
ammonia - which precipitates absorption of nicotine.
When
the product is being burnt, a number of different compounds are formed,
first in the mainstream smoke then immediately afterwards in the secondary
or sidestream smoke. The mainstream smoke derives from the lighted
end of the cigarette and passes through the stem of the cigarette
until it is drawn in at the mouth. The sidestream smoke consists
of the mixture of compounds emitted to the environment from the lighted
tip of the cigarette.
The
following table contains information about the distribution of these
compounds in cigarette smoke and the increased risk that they present
when inhaled. Table 1 below presents the components of
the smoke associated to a greater or lesser degree with the development
of cancer. The IARC (International Agency for Research on Cancer),
is the research reference agency nominated by the World Health Organization
to carry out research and analysis into the compounds suspected of
causing cancer.
Table 1. Chemical substances that are found in the cigarette smoke (listed
in alphabetical order), with the classification of the compounds which
have been proven to be carcinogenic or detailing their respective
carcinogenic potential.
According
to classification by the IARC.
1: Acknowledged to be carcinogenic for humans
2A: Probably carcinogenic for humans
2B: Possibly carcinogenic for humans
3: Not classified as carcinogenic for humans
|
Chemical
compounds
|
IARC
Classi
fication
|
Carcinogenic
potential (mg/kg/d)
|
Target
organs
|
Mainstream
(µg/cig)
|
Sidestream
(µg/cig
|
|
1,3. Butadiene
|
2A
|
3.4
|
reproductive
system / development of fetus
|
35.5
|
191.0
|
|
2-Aminoacenaphtene
|
1
|
1.8
|
. |
0.007
|
0.039
|
|
3-Ethenyl pyridene
|
|
|
. |
662
|
|
|
4-Aminobiphenyl
|
1
|
21
|
. |
0.0012
|
0.01
|
|
4-N-nitrosomethylamine-1-(3- pyridine)-1-butanone (NNK)===
|
2B
|
. |
. |
0.3
|
0.195
|
|
Acetaldehyde
|
2B
|
0.01
|
respiratory
system
|
680
|
1571
|
|
Acetone
|
. |
. |
. |
287
|
917
|
|
Acrolein
|
3
|
. |
respiratory
system ocular system
|
68.8
|
306
|
|
Acrilonitrile
|
2A
|
1
|
respiratory
system
|
8.9
|
86.2
|
|
Ammonia
|
. |
. |
respiratory
system
|
12.2
|
4892
|
|
Arsenic
|
1
|
12
|
development
of fetus cardiovascular system
nervous system
|
0.7
|
.
|
|
Benz(a)anthracene
|
2A
|
0.39
|
. |
0.045
|
. |
|
Benzene
|
1
|
0.1
|
development
of the fetus cardiovascular system
nervous
system
immunologic
system
|
46.3
|
272
|
|
Benzo(a)pyrene
|
2A
|
3.9
|
. |
0.0099
|
0.141
|
|
Benzo(b)fluoranthene
|
2B
|
0.39
|
. |
13
|
. |
|
Benzo(j)fluoranthene
|
2B
|
0.39
|
. |
0.00135
|
. |
|
Benz(k)fluoranthene
|
2B
|
0.39
|
. |
0.009
|
. |
|
Beryllium
|
1
|
8.4
|
. |
0.00025
|
. |
|
Butiraldehyde
|
. |
. |
. |
32.4
|
88.2
|
|
Cadmium
|
1
|
15
|
renal
system
respiratory
system
|
0.103
|
0.736
|
|
Carbon monoxide
|
. |
. |
cardiovascular
system
|
13,609
|
42,451
|
|
Catechol
|
2B
|
. |
. |
88.2
|
164.9
|
|
Polychlorinated Dioxins and Polychlorinated furans
|
1
|
1.3E5
|
development
of fetus immunologic system
respiratory
system endocrine system digestive system
|
0.000075
|
0.000152
|
|
IChromium (hex)
|
1
|
51
|
respiratory
system
|
0.0042
|
0.054
|
|
Chrysene
|
3
|
0.039
|
. |
0.05
|
. |
|
Crotonaldehyde
|
3
|
. |
. |
14.2
|
80.9
|
|
Dibenz(a,h)acridine
|
2B
|
0.39
|
. |
0.0001
|
. |
|
Dibenz(a,j)acridine
|
2B
|
0.39
|
. |
0.0027
|
. |
|
Dibenz(a,h)anthracene
|
2A
|
4.1
|
. |
0.004
|
. |
|
7H-Dibenzo(c,g)carbazole
|
2B
|
3.9
|
. |
0.0007
|
. |
|
Dibenzo(a,i)pyrene
|
2B
|
39
|
. |
0.0025
|
. |
|
Dibenzo(a,l)pyrene
|
2B
|
39
|
. |
. |
. |
|
3-Ethenylpyridene
|
. |
. |
. |
. |
662
|
|
Ethylbenzene
|
. |
. |
development
of fetus
digestive
system
renal
system
|
. |
130d
|
|
Formaldehyde
|
2A
|
0.021
|
respiratory
system
ocular system
|
33.0
|
407.8
|
|
Furfural
|
. |
. |
. |
. |
. |
|
Hydrazine
|
2B
|
17
|
digestive
system
endocrine system
|
0.034
|
. |
|
Hydrogen Cyanide
|
. |
. |
cardiovascular
system
|
118.4
|
106
|
|
Hydrogen Sulphide
|
. |
. |
respiratory
system
|
. |
. |
|
Hydroquinone
|
. |
. |
. |
72.2
|
183.5
|
|
Indeno(1,2,3-c,d)pyrene
|
2B
|
0.39
|
. |
0.012
|
. |
|
Isoprene
|
2B
|
. |
. |
264
|
1140
|
|
Lead
|
2B
|
0.042
|
. |
0.0128
|
0.045
|
|
m + p Cresol
|
. |
. |
cardiovascular
system
|
14
|
79.6
|
|
Mercury
|
. |
. |
nervous
system
|
0.0052
|
. |
|
Methyl Acrylate
|
. |
. |
. |
. |
. |
|
Methyl Chloride
|
.. |
. |
. |
. |
. |
|
5-Methylchrysene
|
2B
|
3.9
|
|
0.0006
|
|
|
Methyl ethyl ketone
|
. |
. |
reproductive
system
|
54.8
|
175.6
|
|
Methylamine
|
. |
. |
. |
. |
. |
|
Methylpyrazine
|
. |
. |
. |
. |
. |
|
Nickel
|
1
|
0.91
|
respiratory
system immunologic system
|
0.011
|
0.031
|
|
Nicotine
|
.. |
. |
. |
. |
919
|
|
Nitric oxide
|
. |
. |
. |
37.7
|
1438
|
|
Nitrogen dioxide
|
. |
. |
respiratory
system
|
. |
. |
|
2-Nitropropane
|
2B
|
. |
. |
0.001
|
. |
|
N-nitrous-n-butylamine (NBA)
|
2B
|
11
|
. |
0.012
|
. |
|
N-nitrous-n-butylamine (NBA)
|
2B
|
11
|
. |
0.012
|
. |
|
N-nitrous-n-butylamine (NBA)
|
2B
|
11
|
. |
0.012
|
. |
|
N-nitrosodiethanolamine
|
2B
|
2.8
|
. |
0.03
|
. |
|
N-nitrosodiethylamine (NDEA)
|
2A
|
36
|
. |
0.0083
|
0.0405
|
|
N-nitrosodimethylamine (NDMA)
|
2A
|
16
|
. |
0.0244
|
1.41
|
|
N-nitrosodiethylamine
|
2B
|
22
|
. |
0.006
|
. |
|
N-nitrosodimorpholine
|
2B
|
6.7
|
. |
. |
. |
|
N-nitrosonornicotine
|
2B
|
1.4
|
. |
1.9
|
49.8
|
|
N-nitrosopyrrolidine (NP)
|
2B
|
21
|
. |
0.113
|
. |
|
Cresol
|
. |
. |
cardiovascular system
|
5.7
|
31
|
|
Phenol
|
. |
. |
digestive system
cardiovascular system
renal system
nervous system
|
26.1
|
330
|
|
Propionaldehyde
|
. |
. |
. |
49.8
|
128.3
|
|
Pyridine
|
. |
. |
. |
11.8
|
250.8
|
|
Pyrrolidine
|
. |
. |
. |
. |
402
|
|
Quinoline
|
. |
. |
. |
0.356
|
10.1
|
|
Resorcinol
|
. |
. |
. |
1.2
|
0.94
|
|
Selenium
|
. |
. |
respiratory system
|
. |
. |
|
Styrene
|
2B
|
. |
nervous
system
|
5.71 c
|
99.5 c
|
|
Toluene
|
. |
. |
nervous
system
digestive
system
|
72.8
|
499
|
|
2-Toluidyne
|
. |
. |
. |
0.115
and
|
. |
|
Urethane
|
2B
|
1
|
. |
0.029
|
. |
|
Vinyl Acetate
|
2B
|
. |
respiratory
system
|
. |
. |
|
Vinyl hydrochloride
|
1
|
0.27
|
. |
0.0086
|
. |
|
Xylenes
|
. |
. |
nervous
system
respiratory
system
|
366
|
. |
Evidence of carcinogenic risk to humans and animals
Aromatic Amines - IARC MONOGRAPHS
on the evaluation of the carcinogenic risk of chemicals to humans,
vol. 38, p. 107-109, 1986
"About
200 amines have been isolated in tobacco smoke. Among these are the
following, which have been proven as possessing carcinogenic effects
in human beings: 2-naphthylomine, 4-aminobiphenyl, ortho-toluidyne,
aniline, N-phenil-2-naftilamine and ortho-anisidine"
Policyclical aromatic hydrocarbonates - IARC MONOGRAPHS on the evaluation of the carcinogenic
risk of chemicals to humans - Tobacco Smoking, vol. 38, pág.100, 1986:
“Analyses
carried out on smoke from cigarettes produced with virginia, burley
and oriental type tobacco have verified the presence of at least 35
different policyclical aromatic hydrocarbonates. The cancerous potential
of those compounds to animals and humans has been exhaustively studied.
Benzo[a]anthracenes and benzopyrenes, are notable as having proven
carcinogenic effects on human beings.
It
was observed that in cigarettes of the bidi
type, the presence of these two compounds was almost twice as high
as compared with common non-filter cigarettes (Comparative chemical analysis of Indian bidi and American cigarette smoke, Hoffmann
et al., Intl. Cancer Journal , pages 14, 49-53, [1974]. "
Benzene - IARC MONOGRAPHS
on the evaluation of the carcinogenic risk of chemicals to humans,
vol. 7, [1986], pages 96-97
"
Benzene is found in the mainstream and sidestream smoke of cigarettes
with and without filters. It is a compound which has already been
widely studied on account of its capacity to cause cancer in humans.
Several
studies have demonstrated the relationship between exposure to benzene
and a number of types of leukaemia" .
As, Cd, Ni and Cr - IARC
- MONOGRAPHS on the evaluation of the carcinogenic risk of chemicals
to humans, vol. 38, [1986]As, , pgs.114 -116; vol.1, pg.. 41; vol.2,
pgs. 48-73; vol.2, pg.. 74-99; vol.2, pgs.. 100-125, vol.2, pgs. 126-149
"The
evidence of cancer causing effects in humans of certain heavy metals
has been thoroughly appraised by the IARC. Compounds such as arsenic
(As), chrome hexavalent (Cr), nickel (Ni) and cadmium (Cd) and compounds
on which these metals are based are associated with cancer in human
beings."
N-Nitrosamines - IARC - MONOGRAPHS on the evaluation
of the carcinogenic risk of chemicals to humans - Tobacco Smoking,
vol. 38, pg. 110-11, [1986]
"Three
different types of N-nitrosamines are produced during the processing
of the tobacco and especially when the tobacco is burning: volatile
n-nitrosamines, non-volatile nitrosamines
and specific nitrosamines of the tobacco. The carcinogenicity of each
one of these has been studied by the IARC. Among the volatile n- nitrosamines,
the N- nitrosodimethylamine (NDMA) predominates and possesses proven
cancerous potential for humans. Among specific N-nitrosamines of
tobacco, those that possess cancerous potential for human beings
are N'-nitrosonornicotine (NNN) and 4-(methylnitrosamine-1-(3-piridil)1-butanone (NNK)."
NO
x: IARC - MONOGRAPHS
on the evaluation of the carcinogenic risk of chemicals to humans,
vol. 38, p. 95-96, vol.27, pg.. 63-80, vol.4, pg.. 127-136 and vol.
29 pg. 331-343
“The
presence of nitrogen oxides in the mainstream smoke can contribute
to the formation of cancerous N-nitrosamines both during the burning
phase of the tobacco as in the human organism following inhalation
of the smoke, affecting both smokers and passive smokers." IARC
- MONOGRAPHS on the evaluation of the carcinogenic risk of chemicals
to humans - Tobacco Smoking, vol. 38, p. 114, 1986
Phenols
and Polyphenols: IARC MONOGRAPHS on the evaluation of the carcinogenic risk of chemicals
to humans, vol. 36 pgs. 75-97
“Over
200 semi-volatile phenols in cigarette smoke were identified. We found
phenols in the top leaves of the tobacco plant. Eugenol is found in
high concentrations in Indonesian cigarettes (cigarettes from Bali
or kreteks). This compound can cause facial
paralysis, among other symptoms."
Database
for Tobacco Products (Sistab)
| >
Form 1 - Company Registration Information |
| >
Form 2 - General List of Types of Tobacco and Additives
Used |
| >
Table 1 - Composition of the Product - Type and amount of tobacco
used in the product |
| >
Table 2 - Composition of the Product - Ingredients and additives
used in the product |
| >
Table 3 - Composition of the Product– Specifications of filter
and wrappers |
| >
Table 4 - Composition of the Product - Studies carried out
|
| >
Table 5 - Compounds present in the mainstream (primary) smoke of
the product |
| >
Table 6 - Compounds present in the sidestream (secondary) smoke
of the product |
| >
Table 7 - Compounds present in overall tobacco |
| >
Table 8 - Data regarding Sale and Production - monthly amount of
the product sold, according to (Brazilian) state
|
| > Table 9 - Data regarding of Sale and Production - monthly amount
of the product exported, by country of destination
|
| >
Table 10 - Data regarding Sale and Production - monthly amount
imported, according to country of origin |
| >
Table 11 - Data regarding Sale and Production - monthly amount produced
|
| >
Table 12 - Data regarding Sale and Production - monthly sale price
to consumer |